Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q4 FY2025 (2025-12-31): 3.80.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-30.18
EARNINGS PER SHARE (EPS) AVG 3Y
-88.49
EARNINGS PER SHARE (EPS) AVG 5Y
-66.35
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Apollomics, Inc.
Market Cap
$50.51M
Earnings Per Share (EPS)
N/A
TTM Avg
-30.18
3Y Avg
-88.49
5Y Avg
-66.35
Market Cap
$50.25M
Earnings Per Share (EPS)
-0.67
TTM Avg
-1.36
3Y Avg
-1.71
5Y Avg
-1.31
Market Cap
$49.96M
Earnings Per Share (EPS)
-3.55
TTM Avg
-4.16
3Y Avg
-5.92
5Y Avg
-5.28
Market Cap
$51.12M
Earnings Per Share (EPS)
-8.95
TTM Avg
-8.42
3Y Avg
-12.89
5Y Avg
-25.33
Market Cap
$51.23M
Earnings Per Share (EPS)
-1.20
TTM Avg
-0.91
3Y Avg
-0.56
5Y Avg
-0.48
Market Cap
$49.50M
Earnings Per Share (EPS)
-2.83
TTM Avg
-3.12
3Y Avg
-4.06
5Y Avg
-22.86
Market Cap
$52.95M
Earnings Per Share (EPS)
N/A
TTM Avg
-7.29
3Y Avg
-67.66
5Y Avg
-178.24
Market Cap
$53.01M
Earnings Per Share (EPS)
-5.21
TTM Avg
-25.08
3Y Avg
-23.14
5Y Avg
-19.79
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apollomics, Inc. (APLM) | $50.51M | N/A | -30.18 | -88.49 | -66.35 |
| Envoy Medical, Inc. (COCH)vs › | $50.25M | -0.67 | -1.36 | -1.71 | -1.31 |
| Clene Inc. (CLNN)vs › | $49.96M | -3.55 | -4.16 | -5.92 | -5.28 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | -8.95 | -8.42 | -12.89 | -25.33 |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | -1.20 | -0.91 | -0.56 | -0.48 |
| Celularity Inc. (CELU)vs › | $49.50M | -2.83 | -3.12 | -4.06 | -22.86 |
| biote Corp. (BTMD)vs › | $49.40M | 0.12 | 0.48 | 0.24 | 1.52 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.95M | N/A | -7.29 | -67.66 | -178.24 |
| ImageneBio Inc (IMA)vs › | $53.01M | -5.21 | -25.08 | -23.14 | -19.79 |
| BioStem Technologies, Inc. (BSEM)vs › | $46.79M | -1.68 | 0.78 | 0.08 | -0.02 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
$-122.00
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -7.57 |
| 2024-12-31 | -52.80 |
| 2023-12-31 | -231.99 |
| 2022-12-31 | -61.60 |
| 2021-12-31 | -23.45 |
| 2020-12-31 | -20.70 |
